Financing ·
IGC Pharma, Inc. entered into Stock Purchase Agreements with CEO Ram Mukunda and VP/PFO Claudia Grimaldi on June 30…
IGCIGC Pharma, Inc.
IGC Pharma, Inc. entered into Stock Purchase Agreements with CEO Ram Mukunda and VP/PFO Claudia Grimaldi on June 30, 2026, to settle outstanding obligations totaling $1,154,210 through the issuance of 4,274,853 shares of common stock at $0.27 per share. The transactions, approved by independent directors, satisfied personal cash advances and other deferred amounts owed to the executives. IGC Pharma, Inc. is a pharmaceutical company.